Insider Buying: 4basebio PLC (LON:4BB) Insider Acquires 46,500 Shares of Stock

4basebio PLC (LON:4BB) insider Heikki Lanckriet purchased 46,500 shares of the stock in a transaction dated Friday, November 15th. The stock was bought at an average cost of GBX 1,325 ($16.80) per share, with a total value of £616,125 ($780,992.52).

4basebio Stock Down 3.1 %

4basebio stock traded down GBX 40 ($0.51) during trading hours on Tuesday, hitting GBX 1,260 ($15.97). The stock had a trading volume of 183 shares, compared to its average volume of 4,601. The stock’s 50-day moving average price is GBX 1,346.45 and its 200-day moving average price is GBX 1,410.28. The stock has a market capitalization of £161.41 million, a P/E ratio of -1,615.38 and a beta of 1.09. 4basebio PLC has a 12-month low of GBX 500 ($6.34) and a 12-month high of GBX 1,820 ($23.07). The company has a quick ratio of 3.52, a current ratio of 2.73 and a debt-to-equity ratio of 201.47.

About 4basebio

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines.